drugset / Trial / NCT01333800

Cost-effectiveness Study of Beclomethasone Versus Ciclesonide as Controller Medications in Pediatric Asthma

NCT01333800

Phase 4 Completed 94 enrolled Grünenthal Colombiana S.A.
RandomizedParallel-groupDouble-blindTreatment

Summary

The Objective was to Develop a Cost-Effectiveness study that compares Ciclesonide and Beclomethasone in pediatric asthma control.

Timeline

Start
2010-07
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Beclomethasone Small molecule 200 ug
Comparator Beclomethasone Small molecule 400 ug
Comparator Ciclesonide Other / unclassified 80 ug
Comparator Ciclesonide Other / unclassified 160 ug

Indications